Is Sun Pharma Advanced Research Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Sun Pharma Advanced Research Co Ltd (SPARC.NS) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Sun Pharma Advanced Research Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sun Pharma Advanced Research Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Sun Pharma Advanced Research Co Ltd?

Muslim investors may consider investing in Sun Pharma Advanced Research Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Sun Pharma Advanced Research Co Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Sun Pharma Advanced Research Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Sun Pharma Advanced Research Co Ltd updated?

The Shariah compliance status of Sun Pharma Advanced Research Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Sun Pharma Advanced Research Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Sun Pharma Advanced Research Co Ltd?

You can check the latest Shariah compliance status of Sun Pharma Advanced Research Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SPARC.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 23, 2026

Report Source: 2026 3rd Quarter Report

Sun Pharma Advanced Research Co Ltd. Stock Analysis SPARC.NS

India Health Care Small Cap Report: Q3, 2026

Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. The company is headquartered in Mumbai, Maharashtra and currently employs 316 full-time employees. The company went IPO on 2007-07-18. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.

Key Statistics of Sun Pharma Advanced Research Co Ltd (SPARC.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹162.56₹172.19

Today's Open

₹170.75

Volume

1.20M

P/E Ratio (TTM)

52 Week Range

₹108.00₹204.40

Market Cap

45.37B

Avg. Volume

3.64M

Dividend Yield

Financial Metrics & Statements of Sun Pharma Advanced Research Co Ltd (SPARC.NS)

FAQ's for Sun Pharma Advanced Research Co Ltd (SPARC.NS)

According to Musaffa’s Shariah screening methodology, Sun Pharma Advanced Research Co Ltd (SPARC.NS) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.